In addition to coronary interventions, the field of cardiovascular intervention has expanded to encompass a wide range of procedures addressing various aspects of cardiovascular health. Transcatheter aortic valve replacement (TAVR) is an innovative intervention for aortic valve stenosis, allowing the replacement of the aortic valve without open-heart surgery. Interventional cardiologists also perform procedures like percutaneous mitral valve repair and closure of atrial septal defects. Advances in technology have led to the development of new devices and techniques, such as drug-eluting stents, bioresorbable vascular scaffolds, and robotic-assisted interventions, further enhancing the precision and effectiveness of cardiovascular interventions. The field continues to evolve with ongoing research, emphasizing a patient-centered approach to tailor interventions based on individual needs and characteristics. Cardiovascular intervention plays a crucial role in providing alternative and effective treatment options for a diverse range of cardiovascular conditions, contributing to improved patient outcomes and quality of life.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India